Addiction Medicine

Altered prefrontal signaling during inhibitory control in a salient drug context in human cocaine addiction
Ahmet O. Ceceli, Muhammad A. Parvaz, Sarah King, Matthew Schafer, Pias Malaker, Akarsh Sharma, Nelly Alia-Klein, Rita Z. Goldstein

medRxiv 2021.09.27.21264113; doi: https://doi.org/10.1101/2021.09.27.21264113

Add to Selected Citations
Deeply-Dyed Nanobead System Based Lateral Flow Assay for Rapid Point-of-Care Drug Testing
Lingzhi Fan, Jianbing Wu, Jing Yang, Fugang Li, Wannian Yan, Fei Tan, Madeline Zhang, Mohamed S. Draz, Huanxing Han, Pengfei Zhang

medRxiv 2021.12.06.21267347; doi: https://doi.org/10.1101/2021.12.06.21267347

Add to Selected Citations
Identifying high-risk comorbidities of short and long-term opioid prescription use
Mariela V Jennings, Hyunjoon Lee, Daniel B Rocha, Sevim B Bianchi, Brandon J Coombes, Richard C Crist, Annika Faucon, Yirui Hu, Rachel L Kember, Travis T Mallard, Maria Niarchou, Melissa N Poulsen, Peter Straub, Richard D Urman, Colin G Walsh, PsycheMERGE Substance Use Disorder Workgroup, Lea K Davis, Jordan W Smoller, Vanessa Troiani, Sandra Sanchez-Roige

medRxiv 2021.11.23.21266717; doi: https://doi.org/10.1101/2021.11.23.21266717

Add to Selected Citations
IMPACT smoking cessation support for people with severe mental illness in South Asia (IMPACT 4S): a protocol for a randomised controlled feasibility trial of a combined behavioural and pharmacological support intervention
Papiya Mazumdar, Gerardo Zavala, Faiza Aslam, Krishna Prasad Muliyala, Santosh Kumar Chaturvedi, Arun Kandasamy, Asad Nizami, Baha Ul Haq, Ian Kellar, Cath Jackson, Heather Thomson, David McDaid, Kamran Siddiqi, Catherine Hewitt, Najma Siddiqi, Simon Gilbody, Pratima Murthy, Noreen Mdege

medRxiv 2021.11.03.21265856; doi: https://doi.org/10.1101/2021.11.03.21265856

Add to Selected Citations
Opioid Use Stigmatization and Destigmatization in Healthcare Professional Social Media
S. Scott Graham, Fiona N. Conway, Richard Bottner, Kasey Claborn

medRxiv 2021.10.19.21265210; doi: https://doi.org/10.1101/2021.10.19.21265210

Add to Selected Citations
Slower Learning Rates from Negative Outcomes in Substance Use Disorder over a 1-Year Period and their Potential Predictive Utility
Ryan Smith, Samuel Taylor, Jennifer L. Stewart, Salvador M. Guinjoan, Maria Ironside, Namik Kirlic, Hamed Ekhtiari, Evan J. White, Haixia Zheng, Rayus Kuplicki, Tulsa 1000 Investigators, Martin P. Paulus

medRxiv 2021.10.18.21265152; doi: https://doi.org/10.1101/2021.10.18.21265152

Add to Selected Citations
Epigenome-wide Association Study of Alcohol Use Disorder in Five Brain Regions
Lea Zillich, Josef Frank, Fabian Streit, Marion M Friske, Jerome C Foo, Lea Sirignano, Stefanie Heilmann-Heimbach, Helene Dukal, Franziska Degenhardt, Per Hoffmann, Anita C Hansson, Markus M Nöthen, Marcella Rietschel, Rainer Spanagel, Stephanie H Witt

medRxiv 2021.08.01.21261118; doi: https://doi.org/10.1101/2021.08.01.21261118

Add to Selected Citations
Decline in prenatal buprenorphine/naloxone fills during the COVID-19 pandemic in the United States
Ashley L. O’Donoghue, Alyse Reichheld, Timothy S. Anderson, Chloe A. Zera, Tenzin Dechen, Jennifer P. Stevens

medRxiv 2021.10.08.21264760; doi: https://doi.org/10.1101/2021.10.08.21264760

Add to Selected Citations
Community social vulnerability and access to medications for opioid use disorder within the continental US: A cross-sectional study
Paul J. Joudrey, Marynia Kolak, Qinyun Lin, Susan Paykin, Vidal Anguiano Jr, Emily A. Wang

medRxiv 2021.09.30.21264351; doi: https://doi.org/10.1101/2021.09.30.21264351

Add to Selected Citations
Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl
Anthony Spadaro, Abeed Sarker, Whitney Hogg-Bremer, Jennifer S Love, Nicole O’Donnell, Lewis S. Nelson, Jeanmarie Perrone

medRxiv 2021.09.24.21264090; doi: https://doi.org/10.1101/2021.09.24.21264090

Add to Selected Citations

Addiction Medicine

Pages